Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis
PMID: 38441048
Source: Expert Rev Clin Pharmacol
Publication date:
2025-07-24
Year:
2024
Abstract
NULL